SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-23-004894
Filing Date
2023-06-29
Accepted
2023-06-29 12:26:16
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm   iXBRL 10-K 885625
2 CERTIFICATION nbio_ex311.htm EX-31.1 13447
3 CERTIFICATION nbio_ex312.htm EX-31.2 13375
4 CERTIFICATION nbio_ex321.htm EX-32.1 5535
5 CERTIFICATION nbio_ex322.htm EX-32.2 4514
11 nbio_10kimg2.jpg GRAPHIC 4594
12 nbio_10kimg1.jpg GRAPHIC 2981
  Complete submission text file 0001477932-23-004894.txt   4308837

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20230331.xsd EX-101.SCH 63008
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20230331_lab.xml EX-101.LAB 279902
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20230331_cal.xml EX-101.CAL 36051
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20230331_pre.xml EX-101.PRE 235507
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20230331_def.xml EX-101.DEF 131519
57 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10k_htm.xml XML 499409
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 231055978
SIC: 2834 Pharmaceutical Preparations